1-20 of 28
Chunyan Ji
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Zinc Oxide Nanoparticles Induce Diffuse Large B-Cell Lymphoma Cell Apoptosis Via Regulating Mitochondrial Dynamics

Zonghong Li, Lili Feng, Chunyan Ji, Ruirong Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 5751.
https://doi.org/10.1182/blood-2024-203463
Published: 2024
Journal Articles

Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin's Lymphoma: Real-World Data in Chinese Population

Zixun Yan, Dehui Zou, Wenbin Qian, Ying Lu, Yuhua Li, Dongmei Ji, Xiaojian Zhu, Heng Mei, Ping Li, Changju Qu, Lei Zhang, Keshu Zhou, Hongmei Jing, Ting Niu, Chunyan Ji, Lanfang Li, Hua Yang, Fei Li, Wei Wang, Kailin Xu, Jinghua Zhao, Depei Wu, Yu Hu, Weili Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 5115.
https://doi.org/10.1182/blood-2024-207186
Published: 2024
Journal Articles

High Remission Rates in Relapsed/Refractory Acute Myeloid Leukemia with QHRD107 (CDK9 Inhibitor), Venetoclax, and Azacitidine Combination Therapy (107VA regimen) : Preliminary Results of a Phase 2a Study

Min Wu, Yunxiang Zhang, Wen Wu, Zheng Ge, Ligen Liu, Chunyan Ji, Weiying Gu, Chunling Wang, Yanli Zhang, Wei Yang, Fuling Zhou, Zhengping Yu, Min Ji, Banghe Ding, Shudong Wang, Lijun Wei, Hengwen Song, Yan Zhou, Bomin Yin, Zhichao Shao, Mengdan Sun, Qi Jiang, Junjie Lu, Junmin Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 2882.
https://doi.org/10.1182/blood-2024-199412
Published: 2024
Journal Articles

Time-Limited of Zanubrutinib, Rituximab and Lenalidomide (ZR2) Regimen for the Treatment of Super-Elderly Diffuse Large B-Cell Lymphoma (DLBCL): A Prospective, Exploratory Clinical Study

Jie Zou, Xiaoning Yu, Xiaoxia Chu, Ji Ma, Zengjun Li, Chunyan Chen, Yan Liu, Jian Xing, Zhongliang Sun, Chunyan Ji, Jie Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 1732.
https://doi.org/10.1182/blood-2024-207021
Published: 2024
Journal Articles

Venetoclax Plus Idarubicin and Cytarabine Chemotherapy As First-Line Treatment for Adults with Acute Myeloid Leukaemia

Shaolei Zang, Min Ji, Jingru Zhang, Fei Lu, Chunqing Zhang, Jingjing Ye, Chunyan Ji
Journal: Blood
Blood (2024) 144 (Supplement 1): 1521.
https://doi.org/10.1182/blood-2024-207613
Published: 2024
Journal Articles

Phase Separation Mediates RUNX1- Mutation Leukemic Transformation

Xiuhua Su, Tao Sun, Yuan Xia, Mingying Li, Dongmei Wang, Fei Lu, Jingjing Ye, Chunyan Ji
Journal: Blood
Blood (2023) 142 (Supplement 1): 4122.
https://doi.org/10.1182/blood-2023-189247
Published: 2023
Journal Articles

Effectivness and Safety of Orelabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective, Real-World Study in China

Kaiyang Ding, Yue-Xin Cheng, Xiaoyong Wang, Chen Huang, Yang Liang, Wei Li, Jingjing Ye, Chunyan Ji
Journal: Blood
Blood (2023) 142 (Supplement 1): 6552.
https://doi.org/10.1182/blood-2023-189115
Published: 2023
Journal Articles

Adiponectin Promote TPO Response for Treating ITP By Relating Rab6A-myosin9 Trafficking Vehicle Carrying c-Mpl to Cell Surface

Xin Zhao, Huixian Ma, Guosheng Li, Tao Sun, Chunyan Ji
Journal: Blood
Blood (2023) 142 (Supplement 1): 5398.
https://doi.org/10.1182/blood-2023-185592
Published: 2023
Journal Articles

Safety and Efficacy Results from the Phase I Study of a Novel Dual Covalent and Non-Covalent Next Generation Inhibitor of Bruton's Tyrosine Kinase LP-168 in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Yuqin Song, Qingqing Cai, Ming Jiang, Keshu Zhou, Lei Zhang, Xiuhua Sun, Zhengming Jin, Lanfang Li, Hongmei Jing, Zhigang Peng, Haiyan Yang, Junyuan Qi, Hui Zhou, Wei Yang, Min Zhou, Chunyan Ji, Wei Xu, Kaiyang Ding, Li Yu, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3033.
https://doi.org/10.1182/blood-2023-180694
Published: 2023
Journal Articles

A Novel Dual Covalent and Non-Covalent Next Generation Inhibitor of Bruton's Tyrosine Kinase LP-168 in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: Safety and Efficacy Results from a Phase 1 Study

Yuqin Song, Qingqing Cai, Ming Jiang, Keshu Zhou, Lei Zhang, Xiuhua Sun, Zhengming Jin, Lanfang Li, Hongmei Jing, Zhigang Peng, Haiyan Yang, Junyuan Qi, Hui Zhou, Wei Yang, Min Zhou, Chunyan Ji, Wei Xu, Kaiyang Ding, Li Yu, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4400.
https://doi.org/10.1182/blood-2023-180485
Published: 2023
Journal Articles

EX103, a Novel CD20xCD3 Bispecific Antibody, Showed a Favorable Safety and Potent Single-Agent Antitumor Activity in Heavily Pretreated Relapsed/Refractory Patients with B-Cell Non-Hodgkin Lymphoma

Junyuan Qi, Mingyuan Sun, Keshu Zhou, Chunyan Ji, Fei Lu, Chunkang Chang, Wenjun Zhang, Daniel Yang, Jiali Lu, Jisen Li, Ying Cheng, Yanfei Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6230.
https://doi.org/10.1182/blood-2023-173486
Published: 2023
Journal Articles

Aberrant Translation Regulated By METTL1/WDR4-Mediated tRNA N 7 -Methylguanosine Modification Drives DLBCL Progression

Chunyan Ji, Xiaomin Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 5727.
https://doi.org/10.1182/blood-2023-186680
Published: 2023
Journal Articles

Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin Lymphoma: Real-World Data in Chinese Population

Zixun Yan, Dehui Zou, Yuhua Li, Xiaojian Zhu, Dongmei Ji, Wenbin Qian, Ying Lu, Chunyan Ji, Keshu Zhou, Hongmei Jing, Hua Yang, Lanfang Li, Fei Li, Kailin Xu, Ting Niu, Depei Wu, Yu Hu, Weili Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6928.
https://doi.org/10.1182/blood-2023-181351
Published: 2023
Journal Articles

The Expression of SREBF1 Inducing By Dexamethasone Promotes Bone Marrow Mesenchymal Stromal Cells Differentiate to Adipocytes to Attract and Protect the Residual T-Cell Acute Lymphoblastic Leukemia Cells

Ruinan Jia, Min Ji, Tao Sun, Jingjing Ye, Chunyan Ji
Journal: Blood
Blood (2022) 140 (Supplement 1): 11434.
https://doi.org/10.1182/blood-2022-167052
Published: 2022
Journal Articles

Profiling Immune Cells in DLBCL Patients with Mass Cytometry By Time-of-Flight (CyTOF)

Fan Zhang, Xiuhua Su, Fei Lu, Jingjing Ye, Chunyan Ji
Journal: Blood
Blood (2022) 140 (Supplement 1): 3591–3592.
https://doi.org/10.1182/blood-2022-168479
Published: 2022
Journal Articles

HDAC1/3-Dependent Moderate Liquid-Liquid Phase Separation of YY1 Promotes METTL3 Expression and AML Cell Proliferation

Meng Li, Mingying Li, Tao Sun, Chunyan Ji
Journal: Blood
Blood (2022) 140 (Supplement 1): 11485.
https://doi.org/10.1182/blood-2022-168417
Published: 2022
Journal Articles

Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updated Long Term Results of Phase II Study

Wei Xu, Yongping Song, Tingyu Wang, Shenmiao Yang, Lihong Liu, Yu Hu, Wei Zhang, Jianfeng Zhou, Sujun Gao, Kaiyang Ding, Huilai Zhang, Zunmin Zhu, Shunqing Wang, Bing Xu, Jianda Hu, Ting Liu, Chunyan Ji, Zhongjun Xia, Yan Li, Xin Wang, Bin Zhang, Renbin Zhao, Jianyong Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 2638.
https://doi.org/10.1182/blood-2021-146491
Published: 2021
Journal Articles

Clinical Correlation of a Precision Medicine Test with Treatment Outcome in Acute Myeloid Leukemia Patients

Hong-Hu Zhu, MD, Min Ji, MD, Chunyan Ji, MD, Chongwu Wang, Yaqiong Ge, Xiaoping Zhou, Julian Gorrochategui, Daniel Primo, PhD, Joan Ballesteros, PhD, Li Li, MD, Joaquin Martinez-López
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-140252
Published: 2020
Journal Articles

Long-Term Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

Yuqin Song, MD PhD, Yongping Song, MD, Lihong Liu, MD, Mingzhi Zhang, MD, Zhiming Li, MD PhD, Chunyan Ji, MD, Wei Xu, MD PhD, Ting Liu, MD PhD, Bing Xu, MD PhD, Xin Wang, MDPhD, Sujun Gao, Huilai Zhang, MD PhD, Yu Hu, MD, Yan Li, Ying Cheng, Haiyan Yang, MD PhD, Junning Cao, Zunmin Zhu, MD, Jianda Hu, MDPhD, Wei Zhang, Hongmei Jing, MD PhD, Kaiyang Ding, Zhengguang Lu, Bin Zhang, PhD, Renbin Zhao, PhD, Zhixin Xu, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-141781
Published: 2020
Journal Articles

Updated Results from the Phase II Study of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

Wei Xu, MD PhD, Yongping Song, MD, Tingyu Wang, Shenmiao Yang, Lihong Liu, MD, Yu Hu, MD, Wei Zhang, Jianfeng Zhou, MD PhD, Sujun Gao, Kaiyang Ding, Huilai Zhang, MD PhD, Zunmin Zhu, MD, Shun-Qing Wang, Bing Xu, MD PhD, Jianda Hu, Ting Liu, MD PhD, Chunyan Ji, MD, Zhongjun Xia, MDPhD, Yan Li, PhDMD, Xin Wang, MDPhD, Huaqiang Zhu, MD, Renbin Zhao, PhD, Bin Zhang, PhD, Zhixin Xu, MD PhD, Jianyong Li, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-134531
Published: 2020